Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression. Zhang T, Kingwell E, De Jong H J, Zhu F, Zhao Y, Carruthers R, Petkau J, Gustafson P, Oger J, Tremlett H Pharmacoepidemiol Drug Saf. 2016 May 23. PMID: 27211481. Abstract CommentRecommendBookmarkWatch
